News

Home » News

PCI Launches High Containment Packaging Facility at Ireland Site

Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) has premiered its new contained packaging facility for the primary and secondary packaging of highly potent products at its newly acquired site near Dublin, Ireland, EU. This latest investment further demonstrates PCI’s ability to provide its current and future customers with the highest standards of excellence [...]

ERT Receives Sixth Consecutive Award for Outstanding Customer Service

ERT, a global data and technology company that minimises uncertainty and risk in clinical trials, has received Omega Management Group Corporation’s NorthFace ScoreBoard (NFSB) Award for consistent delivery of outstanding customer service throughout 2017. This marks the sixth consecutive year that ERT has been recognised for achieving excellence in customer satisfaction, as rated solely by its customers. [...]

Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to Advance PMD-026 Toward IND

Phoenix Molecular Designs (PhoenixMD), a privately held biotechnology company designing precise cancer therapeutics by targeting essential kinases, has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women. Under the terms of the collaboration [...]

Almac Group Continues to Share Expertise as part of North America “Lunch & Learn” Seminar Series

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is delighted to share the completion of its second consecutive bespoke North America “lunch and learn” seminar, building on its global knowledge share series. The complimentary seminar was held at the San Francisco Hilton Hotel on Tuesday 27 March. The [...]

Relocation Reflects Ambitious Growth Plans

Ingenza is pleased to announce its relocation to Roslin Innovation Centre, a £30 million, multipurpose research hub on the University of Edinburgh’s Easter Bush Campus. The centre offers 41,000 sq. ft of flexible laboratory and office space, and Ingenza will occupy 11,000 sq. ft on the top floor, with its own secure access to ensure [...]

Wacker Strengthens Its Pharmaceutical-Protein Business and Buys Dutch Biotechnology Plant

Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg Sàrl. For Wacker, maintaining SynCo’s existing customer relationships is a top priority. Moreover, Wacker is keeping on SynCo’s employees. Both parties have agreed not to disclose the purchase price. “This strategic [...]

Cambrex Invests in New Continuous Flow Technology at its High Point (NC, USA) Facility

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has completed the installation of multiple continuous flow reactor platforms at its High Point (NC, USA) facility. The investment underpins Cambrex’s ongoing commitment to new technologies and aims to reinforce the company’s existing experience in continuous flow. This latest investment [...]

Sartorius Stedim Biotech and Penn State University Announce Partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to enhance the Fermentation Facility that will play a significant role in [...]

Almac Group Expands US Specialised Commercial Packaging Capabilities

Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to announce that it has expanded its US commercial packaging capabilities at its Audubon (PA, USA) facility. Addressing increased client demand of developing and bringing more advanced medicines and niche orphan drugs to market, Almac Pharma Services has enhanced its offering by adding [...]

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Shire, the leading global biotechnology company focused on rare diseases, has entered into a definitive agreement with Servier SAS to sell its oncology business for $2.4 billion. Shire’s Oncology business includes in-market products ONCASPAR (pegaspargase), a component of multi-agent treatment for acute lymphoblastic leukemia (ALL) and ex-US rights to ONIVYDE (irinotecan pegylated liposomal formulation), a component [...]